Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-23

Clinical Trial Update: Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the effect of sarpogrelate in diabetic nephropathy, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sarpogrelate (sarpogrelate)

Snippet

Sponsor: Yuhan Corporation | Conditions: Diabetic Nephropathy | Phase 4 | Status: COMPLETED